Total and differential blood cell counts in metabolically healthy individuals with obesity and subjects with obesity and type 2 diabetes*
| Reference values | Stage 0(n=10) | Stage 2(n=9) | |
| Red blood count (1012/L) | 4.00–5.60 | 4.39±0.31 | 4.49±0.49 |
| White blood count (109/L) | 4.00–11.00 | 6.57±1.39 | 7.52±2.60 |
| Haemoglobin (g/L) | 120–160 | 131.0±9.9 | 136.4±11.0 |
| Haematocrit (L/L) | 0.36–0.48 | 0.40±0.03 | 0.41±0.04 |
| Mean corpuscular volume (fL) | 82–100 | 90.40±2.95 | 91.50±4.23 |
| Mean corpuscular haemoglobin (pg) | 26–34 | 29.85±1.13 | 30.13±2.42 |
| Red cell distribution width (%) | 11–16 | 11.51±0.60 | 10.90±0.82 |
| Platelets (109/L)†,‡ | 150–400 | 277.2±48.4 | 214.2±65.9 |
| Mean platelet volume (fL)† | 5.9–9.8 | 7.90±0.61 | 8.20±0.96 |
| Neutrophils (%) | 50–70 | 58.68±7.87 | 58.30±8.20 |
| Lymphocytes (%) | 20–35 | 29.96±6.64 | 29.09±6.91 |
| Monocytes (%)‡,§ | 1–6 | 7.12±0.83 | 8.05±1.82 |
| Eosinophils (%)‡,§ | 1–3 | 3.38±1.55 | 3.47±2.01 |
| Basophils (%) | 0–1 | 0.85±0.34 | 0.80±0.32 |
| Neutrophils (109/L)§ | 2.00–9.00 | 3.83±1.24 | 4.48±1.98 |
| Lymphocytes (109/L)§ | 0.5–3.30 | 1.89±0.48 | 2.14±0.79 |
| Monocytes (109/L)§ | 0.00–1.00 | 0.45±0.08 | 0.60±0.22 |
| Eosinophils (109/L)§ | 0.00–0.70 | 0.20±0.06 | 0.24±0.10 |
| Basophils (109/L)§ | 0.00–0.20 | 0.07±0.05 | 0.14±0.26 |
* Values are presented as mean ± SD.
†Significant effect of sex in the stage 2 obesity group (p<0.10).
‡Significant correlation with age (n=19, p<0.05) and one-way ANOVA analysis adjusted for age as a confounding factor.
§Analysis was performed on log-transformed values.
¶Indicates mean within a row that is significantly different from the stage 0 obesity group using one-way ANOVA (p<0.05).
ANOVA, analysis of variance.